The global protein a resin market size is expected to reach a value of USD 2.05 billion by 2028 and is poised to grow at a significant CAGR of 6.5% during the forecast period 2022-28. Protein A Resin is a one-step affinity chromatography medium for the purification of immunoglobulin classes, subclasses, as well as fragments from biological fluids and cell culture mediums. Proteins, protein complexes, and antigens can all be immunoprecipitated with Protein A Resin. Agarose is linked to the recombinant protein A ligand. The coupling has been improved to offer immunoglobulin a high binding capacity. Protein A Resin has a higher static binding capability than 20 mg human IgG/ml settled resin.

View detailed report description here https://precisionbusinessinsights.com/market-reports/global-protein-a-resin-market/      

One of the primary factors propelling the protein A resin market is increased investment in protein-based research. E Protein-based research programmes for improved disease therapies are being funded by a variety of private and public entities. The National Institute of Health, for example, invests almost $32.4 million in medical research each year through awarding grants to initiatives and programmes in the life sciences and medical professions. The protein A resin industry is fueled by researchers' growing interest in synthetic biology. Researchers' efforts to build unique machines for manufacturing synthetic proteins are a plus for the market's growth. MIT chemists, for example, have developed a tabletop automated flow synthesis machine that drastically decreases the time it takes to make synthetic proteins. The market for protein A resin is expected to grow as the frequency of chronic diseases rises, leading in a desire for innovative treatments for disease management. According to UN Population Fund figures, those aged 60 and up account for 12.5 percent of the global population, a figure that is expected to rise to nearly 23 percent by 2050. The high frequency of chronic diseases among all those aged 60 and up necessitates the development of innovative therapies. This has an indirect positive impact on the protein A resin market. The recombinant source of protein A resin is expected to rise at a higher rate in the coming years than the other two major sources. This is mostly due to the widespread usage of protein A resins in the extraction processes of monoclonal antibodies.

The global protein a resin market segmentation:
1) By Matrix Type: Agarose based, Glass or Silica, Organic Polymer.
2) Application: Immuno Precipitation, Antibody Purification.
3) End User: Biotechnology and Pharmaceutical industries, Research Laboratories.

North America had the greatest Protein A Resin market share in 2019, but by the end of 2030, it is expected to lose part of that share (7.5 percent). The region's positioning of significant agarose resin manufacturers also including Purolite and Cytiva Life Sciences, formerly known as GE Healthcare, allows it to absorb more than 85 percent of global supply and roughly two-fifth of global demand.

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=15586                                                                                                                            

Some of the major key players in the Protein A Resin Market are Novasep Holding SAS (Novasep) (U.S.) GE Healthcare (U.S.) Thermo Fisher Scientific Inc. (U.S.) E. Merck KG (Merck KGaA) (Germany) Tosoh Corporation (Japan) Repligen Corporation (U.S.) Expedeon Ltd. (U.S.) GenScript (U.S.) JSR Corporation (Japan)

Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747